Clinical presentation and course of acute hepatitis C infection in HIV-infected patients
Article Abstract:
A study is conducted to examine the clinical presentation and the outcomes of acute hepatitis C virus in HIV-infected people by using the antiretroviral therapy. The results show that the unexplained transminase elevations in HIV-infected men should lead to an evaluation of acute HIV infection, which can be treated effectively and accurately by its prompt recognition.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Association between hepatitis C virus coinfection and regional adipose tissue volume in HIV-infected men and women
Article Abstract:
The association between hepatitis C virus (HCV) and adipose tissue volume in HIV-infected men and women is examined. The results have shown that HIV/HCV coinfection is not associated with less subcutaneous adipose tissue (SAT) in men and women, but HCV infection seems to mitigate the loss of leg fat seen in HIV-infected men on stavudine.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy
Article Abstract:
HIV patients have greater than normal amounts of the CCR5 receptor and fewer than normal CXCR4 receptors and this is due to upregulation or downregulation within the subsets rather than a shift in subset proportions. Highly active antiretroviral therapy (HAART) can reduce CCR5 levels but has no effect on CXCR4 levels.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites
- Abstracts: Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future. Introduction
- Abstracts: Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker
- Abstracts: Hepatitis E virus and chronic hepatitis in organ-transplant recipients
- Abstracts: Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP trial